An In-Depth Understanding of OECD's TP Guidelines

Explore the intricacies of transfer pricing within the pharmaceutical sector with this comprehensive course! Gain practical knowledge of the OECD Transfer Pricing Guidelines through engaging lectures and an interactive exercise designed to deepen your understanding of intangible property transfers.

Course Highlights:

• Real-World Scenario: Analyze a detailed case study centered on a multinational pharmaceutical group. This case covers a wide range of business activities, including R&D services, the transfer and use of intangibles, manufacturing services, distribution companies, and financing arrangements.
• Self-Learning Questions: Reinforce your learning with targeted questions that illuminate the complexities of the OECD Transfer Pricing Guidelines. Delve into the landmark legal case of GlaxoSmithKline Holdings (Americas) Inc. v. Commissioner of Internal Revenue, a pivotal transfer pricing dispute impacting the pharmaceutical industry.

Key Topics Covered:

• Understand the essential principles and methods outlined in the OECD Transfer Pricing Guidelines for allocating costs and profits related to intangible property transfers.
• Master the documentation and compliance requirements crucial for effective transfer pricing.
• Identify the risks and challenges faced by multinational corporations in navigating transfer pricing regulations.

Learning Objectives:

• Develop a comprehensive understanding of transfer pricing issues specific to multinational pharmaceutical groups.
• Acquire the knowledge and skills necessary to implement effective transfer pricing policies.
• Ensure compliance with regulations and guidelines, mitigating potential risks and challenges.

This practice test is meticulously crafted to equip you with proficiency in transfer pricing and intangible property transfers within the pharmaceutical industry. Enhance your expertise and confidently navigate the complexities of transfer pricing – join us today!